secwatch.observer — SEC 8-K summary ====================================== Issuer: CROSS COUNTRY HEALTHCARE INC (CCRN) CIK: 0001141103 Form: 8-K Filed at: 2025-12-15T23:59:59+00:00 Accession: 0001628280-25-056873 Event type: leadership Sentiment: neutral Materiality: 0.90 Item codes: 5.02, 7.01, 9.01 LLM model: deepseek-v4-flash:cloud@v2 Cross Country CEO Martins departs; co-founder Clark returns as CEO after Aya deal termination -------------------------------------------------------------------------------- - CEO John Martins separated effective Dec 14, 2025; receives severance of 2-year base salary ($875K) plus average bonus. - Chairman and co-founder Kevin Clark appointed President and CEO; will continue as Chairman. - Transition follows termination of transaction with Aya Healthcare; Board believes it's the right time for change. - Clark previously led Cross Country as CEO from 2019 to 2022, a period of rapid growth and strong financial results. - Company plans to sharpen focus, reduce costs, optimize capital allocation for sustainable profitable growth. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1141103/000162828025056873/0001628280-25-056873-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1141103/000162828025056873/ccrn-20251215.htm HTML page: https://secwatch.observer/filing/0001628280-25-056873 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer